| INTRODUCTION
In 2015, high body mass index (BMI) accounted for approximately 4 million deaths and 120 million disability-adjusted life years globally. 1 Although the prevalence of obesity has been lower among children than adults, the rate of increase in the prevalence of childhood obesity has been faster than that of adult obesity. 1 Obesity has become one of the most challenging health problems in children and its prevalence is increasing worldwide. [1] [2] [3] Obesity is the most common cause of insulin resistance in children, and obese subjects are at greater risk of comorbid conditions such as dyslipidemia, type 2 diabetes mellitus (T2DM), and long-term vascular complications. 4, 5 Understanding the incidence of obesity is key to understanding the risk over a lifetime and identifying potential ages for intervention. 6 Therefore, there is an urgent need to determine novel methods of preventing and treating childhood obesity.
Abbreviations: BMI, body mass index; BMI-SDS, BMI SD score; HbA1c, glycated hemoglobin; HC, hip circumference; HDL cholesterol, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL cholesterol, low-density lipoprotein cholesterol; MDP, mitochondrial-derived peptide; MOTS-c, mitochondrial open reading frame of the 12S rRNA-c; TC, total cholesterol; TG, triglyceride; WC, waist circumference; WHR, waist-to-hip ratio
In obese animal models and patients, metabolic disturbances associated with mitochondrial dysfunction, including reduced mitochondrial mass and mitochondrial biogenesis, altered mitochondrial morphology, and structural damage, have been identified. 7, 8 Also, a novel bioactive mitochondrial-derived peptide (MDP)-mitochondrial open reading frame of the 12S rRNA-c (MOTS-c)-encoded in the mitochondrial DNA, was recently identified. 9 Previous studies have demonstrated that MOTS-c treatment in mice prevented agedependent and high-fat diet-induced insulin resistance, as well as diet-induced obesity via AMP-activated protein kinase (AMPK), which is a well-characterized regulator of energy metabolism, and is capable of ameliorating obesity and T2DM. 9, 10 Since MOTS-c has been discovered to regulate insulin sensitivity and metabolic homeostasis, it is expected to play an important role in metabolism and to open a new pathway for the possible prevention of and therapy for obesity and T2DM. 9, 10 If these findings in mice were found to be fully applicable to Correlations between variables were assessed using Pearson's correlation analysis for normally distributed data or Spearman's correlation analysis for data with non-normal distribution. P-values (2-tailed) <.05
were considered statistically significant.
3 | RESULTS
| Circulating MOTS-c levels were decreased in obese male children and adolescents
The baseline characteristics of the control and obese children and adolescents are described in Tables 1, S1 (Table 1) .
Strikingly, MOTS-c levels were decreased in obese children and adolescents when compared with control subjects (472.61 AE22.83 vs 561.64 AE19.19 ng/mL, P < .01) ( Figure 1A ,B). There were no significant differences in MOTS-c levels between the male and female cohorts (536.19 AE17.47 vs 499.77 AE30.29 ng/mL, P > .05, respectively) ( Figure 2A ). There was also no difference between the control and obese subjects (males vs females: 584.1 AE21.18 vs 508.85 AE 38.76 ng/mL, P > .05; 465.26 AE24.53 vs 487.89 AE49.77 ng/mL, P > .05, respectively) ( Figure 2B ). Remarkably, MOTS-c levels were significantly decreased in obese male subjects compared to their control counterparts (465.26 AE24.53 vs 584.07 AE21.18 ng/mL, P < .001, Figure 2B ), whereas they were comparable between the control and obese female subjects (508.85 AE38.76 vs 487.89 AE49.77 ng/mL, P > .05, Figure 2B ). Next, there were significant differences in MOTSc levels between control and obese male groups (prepubertal vs Figure 3 ). These data suggest that circulating MOTS-c levels are decreased in obese male but not obese female children and adolescents.
3.2 | The degree of decline in circulating MOTS-c levels is more obvious in insulin-resistant obese male children and adolescents
As obesity is the most common cause of insulin resistance, we tested whether insulin resistance further attenuates endogenous MOTS-c expression. The comparisons of male subjects with normal BMI and non-insulin resistant obesity or insulin-resistant obesity are described in Table 2 . There were significant differences in the levels and values of BMI, BMI-SDS, WC, HC, fasting insulin, HOMA-IR, HbA1c, LDL cholesterol, and uric acid between both groups (all P values <.01).
Additionally, MOTS-c levels were significantly decreased among the insulin-resistant obese subjects when compared with the control chil- Figure 4B ).
When we compared the 3 groups in the female cohort, there were no significant differences in MOTS-c levels between each pair of children and adolescents with normal BMI, non-insulin resistant obesity and insulin-resistant obesity (all P values >.05) ( Figure S1 ). These studies suggest that the degree of decline in circulating MOTS-c levels is more obvious in male children and adolescents with insulin-resistant obesity. 
| Correlations between MOTS-c level and related variables
Next, we studied the correlations of circulating MOTS-c levels with age, fasting glucose and insulin levels, HOMA-IR, HbA1c, sex hormones, and plasma lipid profiles in the control and obese groups;
however, there were no significant differences (all P values >.05) (Table S3) . After controlling for sex among all male participants, the correlations between MOTS-c levels and age, or the levels of fasting glucose, TC, TG, HDL-C, LDL-C, uric acid, and sex hormones were unchanged (Table S4) . Notably, we observed that MOTS-c levels were negatively correlated with BMI (r = −0.521, P < .001; Figure 5A ), BMI-SDS (r = −0.488, P < .001; Figure 5B ), WC (r = −0.559, P < .001; Figure 5C ), WHR (r = −0.314, P = .010; Figure 5D ), fasting insulin level (r = −0.379, P = .002; Figure 5E ), HOMA-IR (r = −0.380, P = .001; Figure 5F ), and HbA1c (r = −0.271, P = .027) in all male subjects. Nevertheless, the results showed that there were no associations between MOTS-c level and the above variables among all female subjects (Table S5) . These results further indicate that circulating MOTS-c levels are correlated with markers of obesity and insulin resistance in obese male children and adolescents.
| DISCUSSION
Childhood obesity is a health problem of grave concern worldwide.
Among children who had become overweight during the preschool years, incident obesity between the ages of 5 and 14 years was more likely to have occurred at younger ages. 6 Therefore, the participants enrolled in the current study were between 5 and 14 years of age.
MOTS-c was recently discovered to regulate insulin sensitivity
and metabolic homeostasis. 9 Moreover, there are very few studies on MOTS-c and have yet to be reproduced in the human obese model.
Given the promising therapeutic effects of MOTS-c on obesity and
T2DM, further studies are required to understand the natural course of MOTS-c expression and activity in obese and diabetic subjects from a diagnostic point of view, and to determine its translational role and therapeutic potential in the management of these diseases. 17, 18 To the best of our knowledge, this is the first study in which MOTS-c levels have been reported in relation to human obesity. We found that circulating MOTS-c levels were decreased in obese male children and adolescents. In addition, the degree of decline in circulating MOTS-c levels is more obvious in obese male insulin-resistant children and adolescents. Notably, MOTS-c levels were negatively correlated with markers of insulin resistance and obesity in the male cohort.
We determined that MOTS-c levels were significantly decreased in obese male children or adolescents compared with male control subjects, while they were comparable between healthy control and obese female subjects. Obesity is highly heritable and shows marked sex differences. 19 Some studies have noted the sex differences in the heritability of obesity-related traits, such as BMI, WC, WHR, and body composition. [19] [20] [21] Sexual dimorphism in mitochondrial features, including mitochondrial mass and biogenesis, oxidative capacity, and antioxidant defenses, has been identified in many rat tissues, such as liver, adipose tissue, and skeletal muscle. [22] [23] [24] [25] Furthermore, MOTS-c appears to directly target skeletal muscle, and muscle mitochondria from females produced dramatically less hydrogen peroxide and showed greater resistance to oxidative stress than those from males. 9, 23, 26 The resistance of mitochondrial function to oxidative stress and the antioxidant responses are sex-dependent, and may be related to the protective effects of estrogen, 26 which was known to , and obese female (n = 13) groups. Data are shown as mean AESEM. **P < .01; NS, no significance
Comparison of plasma MOTS-c levels in the male cohort according to pubertal status: prepubertal control (n = 30), prepubertal obese (n = 12), pubertal control (n = 10), and pubertal obese (n = 15). Data are shown as mean AESEM. *P < .05 activate specific mitochondrial biogenesis. 27 It may thus lead to the compensatory effects on the expression of MOTS-c in obese females.
It is worth mentioning that all the mice selected in the aforementioned animal experiment were male 9 ; the expression of MOTS-c in female mice has not yet been reported. Moreover, sex hormones may be responsible for sex differences in glucose homeostasis, prediabetic syndromes, type 1 diabetes mellitus, and T2DM. 28 As such, MOTS-c levels might be affected by factors such as genetic effects, sex, and sex hormones in children and adolescents.
Beyond sex difference, we also found that circulating MOTS-c levels were obviously decreased in insulin-resistant obese male children and adolescents, and negatively correlated with indices of insulin resistance. More importantly, our findings were consistent with previous studies (mice) which demonstrated that endogenous MOTS-c levels in circulation decline concomitantly with the development of insulin resistance during aging. 9 In youths and adults with T2DM, insulin resistance is associated with muscle mitochondrial dysfunction. 7, [29] [30] [31] [32] In addition, a recent study demonstrated that in adipose tissue from obese children, there was dysregulation of mitochondrial function and biogenesis modulators relative to lean subjects. 8 As MOTS-c is a key novel endocrine signaling molecule that originates from mitochondria, mitochondrial DNA dysfunction could result in a direct decline in mitochondrial function and progressive loss of MDP expression, which will diminish their functionality as regulatory peptides. 9 Thus, it is tempting to speculate that the significantly decreased levels of endogenous MOTS-c in insulin-resistant obese children and adolescents may be a consequence of mitochondrial dysfunction, and that the expression of MOTS-c decreases dramatically , and IRobese male group (n = 10) are shown as mean AESEM. *P < .05, **P < .01 when the mitochondrial dysfunction reaches a certain threshold, but the presence of such a mechanism remains to be elucidated.
Abdominal obesity, hypertension, increased triacylglycerol concentrations, and low HDL-cholesterol levels are characteristic of insulin resistance. 33 There was a negative correlation between MOTS-c levels and BMI, BMI-SDS, WC, WHR among all male patients, while there was no correlation between MOTS-c and triacylglycerol or HDL-cholesterol levels. Notably, increased triacylglycerol levels and decreased HDL-cholesterol levels were shown in obese male subjects compared with control male subjects; it is compelling to propose induced by drugs such as metformin. 11 For these reasons, MOTS-c may be a novel potential treatment for obesity and T2DM, and may prove beneficial in future studies of specific patient populations.
Our study included subjects who were newly diagnosed obese patients without any prior history of anti-obesity treatment; thus, their MOTS-c levels likely accurately reflected the natural MOTS-c profiles. Despite these strengths, we need to acknowledge several limitations in the present study. The number of subjects enrolled, particularly females, was small and the age range of the participants was narrow. Additionally, this study was conducted at a single center in China; therefore, our results may not represent the general population of China. The results of our study need to be confirmed in other ethnic contexts in the future. Nevertheless, our study cohort was well defined, and evident differences were demonstrated.
In conclusion, we demonstrated that the levels of circulating MOTS-c are decreased in obese male children and adolescents, and 
